2019 Q4 Form 10-K Financial Statement

#000143774920006294 Filed on March 27, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2019 2018 Q4
Revenue $2.570M $13.64M $2.980M
YoY Change -13.76% 32.77% 43.27%
Cost Of Revenue $1.000M $5.342M $1.100M
YoY Change -9.09% 38.86% 26.44%
Gross Profit $1.570M $8.301M $1.880M
YoY Change -16.49% 29.12% 55.37%
Gross Profit Margin 61.09% 60.84% 63.09%
Selling, General & Admin $740.0K $2.480M $580.0K
YoY Change 27.59% -8.69% -3.33%
% of Gross Profit 47.13% 29.88% 30.85%
Research & Development $540.0K $1.314M $410.0K
YoY Change 31.71% 6.22% 10.81%
% of Gross Profit 34.39% 15.83% 21.81%
Depreciation & Amortization $40.00K $184.0K $30.00K
YoY Change 33.33% 38.35% -40.0%
% of Gross Profit 2.55% 2.22% 1.6%
Operating Expenses $1.280M $3.794M $990.0K
YoY Change 29.29% -4.02% 2.06%
Operating Profit $290.0K $4.507M $890.0K
YoY Change -67.42% 82.03% 270.83%
Interest Expense $0.00 $46.00K -$50.00K
YoY Change -100.0% -75.66% 0.0%
% of Operating Profit 0.0% 1.02% -5.62%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $300.0K $4.465M $850.0K
YoY Change -64.71% 95.23% 347.37%
Income Tax
% Of Pretax Income
Net Earnings $300.0K $4.465M $850.0K
YoY Change -64.71% 95.23% 347.37%
Net Earnings / Revenue 11.67% 32.73% 28.52%
Basic Earnings Per Share $0.32
Diluted Earnings Per Share $19.39K $0.28 $54.66K
COMMON SHARES
Basic Shares Outstanding 13.50M
Diluted Shares Outstanding 15.35M

Balance Sheet

Concept 2019 Q4 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.300M $3.300M $1.700M
YoY Change 94.12% 94.12% 750.0%
Cash & Equivalents $3.334M $3.300M $1.652M
Short-Term Investments
Other Short-Term Assets $200.0K $200.0K $100.0K
YoY Change 100.0% 100.0% 0.0%
Inventory
Prepaid Expenses $152.0K $91.00K
Receivables $1.566M $1.600M $1.967M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.052M $5.100M $3.710M
YoY Change 36.17% 37.84% 187.6%
LONG-TERM ASSETS
Property, Plant & Equipment $335.0K $1.700M $200.0K
YoY Change 67.5% 466.67% 61.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $38.00K $0.00 $38.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $1.783M $1.700M $359.0K
YoY Change 396.66% 325.0% 121.6%
TOTAL ASSETS
Total Short-Term Assets $5.052M $5.100M $3.710M
Total Long-Term Assets $1.783M $1.700M $359.0K
Total Assets $6.835M $6.800M $4.069M
YoY Change 67.98% 65.85% 180.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $252.0K $300.0K $193.0K
YoY Change 30.57% 50.0% -0.52%
Accrued Expenses $828.0K $1.100M $1.403M
YoY Change -40.98% -21.43% 42.0%
Deferred Revenue $516.0K $1.004M
YoY Change -48.61% 147.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $1.943M $1.900M $3.252M
YoY Change -40.25% -42.42% 56.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $1.900M
YoY Change -100.0% -100.0% -34.48%
Other Long-Term Liabilities $1.300M $1.300M
YoY Change
Total Long-Term Liabilities $1.336M $1.300M $1.879M
YoY Change -28.9% -31.58% -35.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.943M $1.900M $3.252M
Total Long-Term Liabilities $1.336M $1.300M $1.879M
Total Liabilities $3.279M $3.300M $5.131M
YoY Change -36.09% -35.29% 2.62%
SHAREHOLDERS EQUITY
Retained Earnings -$54.78M -$59.24M
YoY Change -7.54% -3.72%
Common Stock $136.0K $133.0K
YoY Change 2.26% 3.91%
Preferred Stock
YoY Change
Treasury Stock (at cost) $362.0K $362.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares $10.00K $10.00K
Shareholders Equity $3.556M $3.600M -$1.062M
YoY Change
Total Liabilities & Shareholders Equity $6.835M $6.800M $4.069M
YoY Change 67.98% 65.85% 180.23%

Cashflow Statement

Concept 2019 Q4 2019 2018 Q4
OPERATING ACTIVITIES
Net Income $300.0K $4.465M $850.0K
YoY Change -64.71% 95.23% 347.37%
Depreciation, Depletion And Amortization $40.00K $184.0K $30.00K
YoY Change 33.33% 38.35% -40.0%
Cash From Operating Activities $1.350M $4.290M $790.0K
YoY Change 70.89% 66.41%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K $260.0K -$30.00K
YoY Change 166.67% 28.71% 200.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$80.00K -$260.0K -$30.00K
YoY Change 166.67% 28.71%
FINANCING ACTIVITIES
Cash Dividend Paid $714.0K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K -2.348M 40.00K
YoY Change -250.0% 147.68% -233.33%
NET CHANGE
Cash From Operating Activities 1.350M 4.290M 790.0K
Cash From Investing Activities -80.00K -260.0K -30.00K
Cash From Financing Activities -60.00K -2.348M 40.00K
Net Change In Cash 1.210M 1.682M 800.0K
YoY Change 51.25% 17.79% -2766.67%
FREE CASH FLOW
Cash From Operating Activities $1.350M $4.290M $790.0K
Capital Expenditures -$80.00K $260.0K -$30.00K
Free Cash Flow $1.430M $4.030M $820.0K
YoY Change 74.39% 69.61% 8100.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000736012
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1237000
CY2019 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Greater Than Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceGreaterThanMarketValue
CY2018 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Greater Than Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceGreaterThanMarketValue
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13753030
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
46588000
CY2019 dei Entity Registrant Name
EntityRegistrantName
Intrusion Inc
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Security12g Title
Security12gTitle
Common Stock, $0.01 par value
CY2019 intz Defined Contribution Plan Minimum Age Required For Contribution Of Additional Amount Of Salary Per Year
DefinedContributionPlanMinimumAgeRequiredForContributionOfAdditionalAmountOfSalaryPerYear
P50Y
CY2019 intz Extinguishment Of Uk Cumulative Translation
ExtinguishmentOfUkCumulativeTranslation
CY2018 intz Extinguishment Of Uk Cumulative Translation
ExtinguishmentOfUkCumulativeTranslation
64000
CY2019Q4 intz Lessee Operating And Finance Lease Liability Payments Due
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue
1890000
CY2019Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Five
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFive
352000
CY2019Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Four
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFour
380000
CY2019Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Three
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearThree
369000
CY2019Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Two
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearTwo
382000
CY2019Q4 intz Lessee Operating And Finance Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextRollingTwelveMonths
407000
CY2019 intz Number Of Major United States Financial Institutions
NumberOfMajorUnitedStatesFinancialInstitutions
2
CY2019Q4 intz Number Of Stockbased Compensation Plans
NumberOfStockbasedCompensationPlans
2
CY2019 intz Operating Lease Rightofuse Asset Amortization Expense
OperatingLeaseRightofuseAssetAmortizationExpense
232000
CY2018 intz Operating Lease Rightofuse Asset Amortization Expense
OperatingLeaseRightofuseAssetAmortizationExpense
CY2019 intz Penalties And Waived Penalties On Dividends
PenaltiesAndWaivedPenaltiesOnDividends
6000
CY2018 intz Penalties And Waived Penalties On Dividends
PenaltiesAndWaivedPenaltiesOnDividends
47000
CY2019 intz Period Of Payment Terms Offered To Customers Distributions And Resellers Domestically
PeriodOfPaymentTermsOfferedToCustomersDistributionsAndResellersDomestically
P30D
CY2019 intz Period Of Payment Terms Offered To Customers Distributors And Resllers Internationally
PeriodOfPaymentTermsOfferedToCustomersDistributorsAndResllersInternationally
P45D
CY2019 intz Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period2
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod2
P3Y
CY2019 intz Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period3
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod3
P5Y
CY2019 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
34000
CY2018 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
24000
CY2019 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Greater Than Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceGreaterThanMarketValue
CY2018 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Greater Than Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceGreaterThanMarketValue
CY2019 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Expiration Term For Options Granted To Holders Of More Than Specified Percentage Of Voting Stock
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationTermForOptionsGrantedToHoldersOfMoreThanSpecifiedPercentageOfVotingStock
P5Y
CY2019 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
4.40
CY2018 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
1.15
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
252000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
193000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1566000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1967000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
245000
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
170000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
828000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1403000
CY2019Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
CY2018Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
191000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
193000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
154000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
311000
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
310000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
909000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
787000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56759000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56609000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30630
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2019Q4 us-gaap Assets
Assets
6835000
CY2018Q4 us-gaap Assets
Assets
4069000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
5052000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
3710000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
128000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3334000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1652000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
224000
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1682000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1428000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2491543
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13552000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13259000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13542000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13249000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
136000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
133000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Risk Concentration</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major U.S. financial institutions. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that we are subject to any unusual financial risk with our banking arrangements. We have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any significant losses on our cash and cash equivalents.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We sell our products to customers primarily in the United States. In the future, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>sale our products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company&#x2019;s operating results. We perform ongoing credit evaluations of our customers&#x2019; financial condition and generally require <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.</div></div></div></div></div></div></div></div></div></div></div>
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1566000
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1967000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
516000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1004000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5342000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3847000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19172000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21204000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18771000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20720000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
374000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
374000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
68000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
78000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
4000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
36000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
28000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19172000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21204000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
77000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
32000
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
30000
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.0025
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
184000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133000
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
20000
CY2018Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
594000
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
139000
CY2018Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
139000
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y65D
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
86000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1599000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
284000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1315000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000
CY2018 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
5000
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
4000
CY2018 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
64000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
43000
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
58000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
21000
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
64000
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
66000
CY2019Q4 us-gaap Finance Lease Liability Payments Due In Next Rolling Twelve Months
FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
45000
CY2019Q4 us-gaap Finance Lease Liability Payments Due In Rolling Year Five
FinanceLeaseLiabilityPaymentsDueInRollingYearFive
CY2019Q4 us-gaap Finance Lease Liability Payments Due In Rolling Year Four
FinanceLeaseLiabilityPaymentsDueInRollingYearFour
CY2019Q4 us-gaap Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
CY2019Q4 us-gaap Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
21000
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
58000
CY2018 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
66000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
62000
CY2018Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
121000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
59000
CY2018 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
65000
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1182000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1112000
CY2019 us-gaap Gross Profit
GrossProfit
8301000
CY2018 us-gaap Gross Profit
GrossProfit
6429000
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4465000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2287000
CY2019Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
294000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018 us-gaap Operating Lease Payments
OperatingLeasePayments
264000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2030000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-450000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
938000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
480000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
10000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-91000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
16000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
4000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1066000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
57000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-496000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
421000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-401000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1005000
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
401000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-488000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
598000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-15000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
61000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2000
CY2019 us-gaap Interest Expense
InterestExpense
46000
CY2018 us-gaap Interest Expense
InterestExpense
189000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
513000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
479000
CY2019 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
4000
CY2018 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
63000
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
63000
CY2019Q4 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P3Y
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1824000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
352000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
380000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
369000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
361000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
362000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
225000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6835000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4069000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1943000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3252000
CY2019 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.</div> Coronavirus Outbreak in the United States</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 36pt;"><div style="display: inline; font-weight: bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </div>Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of federal government entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results.&nbsp; The extent of the impact of COVID-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19</div> on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers, employees and vendors all of which are uncertain and cannot be predicted.&nbsp; A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>require additional cost and effort should our employees <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be able to be physically on-premises.</div></div>
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1138000
CY2018Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
881000
CY2019 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Description of Business</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We develop, market, and support a family of entity identification, data mining, regulated information compliance and data privacy protection. Our product families include: TraceCop for identity identification, Savant for data mining and advanced persistent threat detection and Compliance Commander for regulated information and data privacy protection. Intrusion&#x2019;s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We market and distribute our products through a direct sales force to end-users, distributors and numerous system integrators, managed service providers and value-added resellers. Our end-user customers include banks, credit unions, other financial institutions, U.S. federal government entities, foreign government entities, hospitals and other healthcare providers. Essentially, our end-users can be defined as end-users requiring network security solutions for protecting their mission critical data.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">References to the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d;, &#x201c;Intrusion&#x201d; or &#x201c;Intrusion&nbsp;Inc.&#x201d; refer to Intrusion&nbsp;Inc. and its subsidiaries. Compliance Commander&#x2122; and TraceCop&#x2122; are registered trademarks of Intrusion Inc.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>we had cash and cash equivalents of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,334,000,</div> up from approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,652,000</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>We generated a net income of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,465,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>compared to a net income of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,287,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on the current forecast for the year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020,</div> we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2021. </div>As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 24, 2019, </div>our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing base and assessing what terms <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be available to the Company, including whether any such terms available are acceptable to the Company, if at all (the &#x201c;Potential Replacement Facility&#x201d;). Any equity or debt financings, if available at all, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be on terms which are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> favorable to us and, in the case of equity financings, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>result in dilution to our stockholders. We expect to fund our operations through anticipated Company profits, possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly, and a possible Potential Replacement Facility. If our operations do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate positive cash flow in the upcoming year, or if we are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be unable to implement our business plan, fund our liquidity needs or even continue our operations.</div></div>
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2348000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-948000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-260000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-202000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4290000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2578000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
4465000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
2287000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4326000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2148000
CY2019Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
CY2018Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1815000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
4507000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
2476000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
433000
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
316000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1348000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
79000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
99000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
714000
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
260000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
202000
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
139000
CY2018 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
139000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
152000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
91000
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
150000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
239000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
168000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1244000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
987000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
335000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200000
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1815000
CY2018 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1200000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1314000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54777000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59242000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13643000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10276000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1298000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1604000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
47000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
20000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.2458
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.2521
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0083
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
917000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1172000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.84
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.84
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
84000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.69
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.49
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1235000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1746000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
975000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.83
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.68
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.96
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4411000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
970000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.95
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.81
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.37
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.22
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
917000
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
975000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y332D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4278000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y259D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y14D
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.84
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.96
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y29D
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
294000
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
451000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
3556000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1062000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10000
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
362000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
362000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.</div></div></div></div></div></div></div></div></div></div></div>
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15352000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15063000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13502000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13049000

Files In Submission

Name View Source Status
0001437749-20-006294-index-headers.html Edgar Link pending
0001437749-20-006294-index.html Edgar Link pending
0001437749-20-006294.txt Edgar Link pending
0001437749-20-006294-xbrl.zip Edgar Link pending
ex_178441.htm Edgar Link pending
ex_178442.htm Edgar Link pending
ex_178443.htm Edgar Link pending
ex_178444.htm Edgar Link pending
ex_178445.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
intz-20191231.xml Edgar Link completed
intz-20191231.xsd Edgar Link pending
intz-20191231_cal.xml Edgar Link unprocessable
intz-20191231_def.xml Edgar Link unprocessable
intz-20191231_lab.xml Edgar Link unprocessable
intz-20191231_pre.xml Edgar Link unprocessable
intz20191231_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending